The FDA label update boosts GE HealthCare’s Vizamyl to a market advantage despite the emergence of blood-based tests.

A novel molecular imaging agent targeting glypican-3 (GPC3) has demonstrated high sensitivity and specificity in detecting ...

The fight against cancer in the country has received another major boost after Nairobi West Hospital announced that it had ...

Determining the specific type of dementia early in the diagnostic process can lead to more targeted treatments and better outcomes ...

Dave Coulier recalled the moment he got diagnosed with cancer, his immunity problems after chemotherapy, and the beacons of ...

For the first time, a new PET imaging technique has successfully visualized three radiotracers in a single scan, according to ...

FDA approved to help select patients with metastatic prostate cancer for radioligand therapy before chemotherapy.

PET/CT findings will be defined as true negative (TN), if the scan was negative and no distant disease was detected during further follow-up. PET/CT results will be defined as false negative (FN), if ...

Mogensen AW et al. The Use of PSMA PET/CT Improves Overall Survival in Men with Biochemically Recurrent Prostate Cancer ...

The unwelcome news came in September, when a full-body PET scan that tracks cancer hot spots showed that my sarcoma had ...

Adventist Health Ukiah Valley recently unveiled its new PET/CT machine, which will offer faster results and peace of mind for ...

BAMF Health in Grand Rapids has launched a study to identify markers for targeted breast cancer therapies using PET scans.